Pharmaceutical R&D spending and threats of price regulation
Year of publication: |
2010
|
---|---|
Authors: | Golec, Joseph ; Hegde, Shantaram P. ; Vernon, John A. |
Published in: |
Journal of financial and quantitative analysis : JFQA. - New York, NY [u.a.] : Cambridge University Press, ISSN 0022-1090, ZDB-ID 219406-5. - Vol. 45.2010, 1, p. 239-264
|
Subject: | Börsenkurs | Share price | Pharmaindustrie | Pharmaceutical industry | Forschungskosten | Research expenditure | Preisregulierung | Price regulation | USA | United States | 1985-2006 |
-
Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending
Golec, Joseph, (2005)
-
Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
Golec, Joseph H., (2010)
-
Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
Golec, Joseph, (2005)
- More ...
-
Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence
Vernon, John A., (2008)
-
An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending
Vernon, John A., (2009)
-
Financial risk in the biotechnology industry
Golec, Joseph, (2007)
- More ...